Teleflex Incorporated (TFX) has a MoatMap StockRank of 67/100 based on Quality (47/100), Value (29/100), and Momentum (74/100) factor scores. The current signal is BUY. Teleflex is a medical device manufacturer with mediocre quality metrics (Q-score 47). It does not align with our CDMO pricing power theme or any other structural tailwinds, making it a generic healthcare holding.
Teleflex Incorporated is a global provider of specialized medical technologies aimed at improving patient health, focusing on product areas such as vascular access, anesthesia, surgical, urology, and interventional cardiology. Its competitive moat is formed by proprietary technologies, robust clinical evidence supporting product efficacy, and established relationships with healthcare providers worldwide. Teleflex is a key innovator in acute care and surgical medical devices.
| Price | $132.11 |
| Market Cap | $5.7B |
| P/E (TTM) | 1887.29 |
| P/E (Forward) | 12.63 |
| Price/Book | 1.90 |
| Return on Equity | 0.0% |
| Return on Invested Capital | 2.0% |
| Debt/Equity | 88.79 |
| Gross Margin | 55.3% |
| Operating Margin | 8.4% |
| Revenue Growth | 32.3% |
| Dividend Yield | 1.0% |
| Free Cash Flow | $-4M |
Teleflex Incorporated operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).